公司资料
Elevance Health 股价、新闻与催化剂
- 股票代码:
- ELV
- 交易所:
- NYSE
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
390.24 USD (-2.52%)
收盘价
最后更新: 2026年8月17日
84.5B USD
市值
股价为何变动
As of Aug 17, 2026, ELV closed down 2.52% at $390.24. No new same-company headline was identified in the current news window.
公司概览
业务概览
Elevance Health is a diversified healthcare company focused on health benefits, care delivery, and services. Its story is shaped by managed-care scale, medical cost discipline, and the breadth of its healthcare platform.
所在地与行业分类
Headquartered in the United States and listed on NYSE, Elevance is primarily a U.S.-focused managed-care company. Its footprint is broad across commercial, government, and specialty healthcare programs.
商业模式特征
The business depends on premium revenue, healthcare services, and effective management of medical cost trends. Investors watch membership, pricing, care utilization, and operating discipline rather than drug-development catalysts.
生物医药行业定位
Elevance is not a biotech name, but it matters to healthcare investors because it sits at the payer-services core of the system. Its stock is driven by utilization and policy sensitivity, not clinical trial events.
未来催化剂
- Elevance Health’s catalysts are earnings, medical-benefit ratio commentary, and any update on Medicaid or Medicare utilization trends. This matters because it helps show whether the company can turn its current footprint into a cleaner earnings profile. Better execution here can matter even before a new product or trial headline lands.
近期新闻
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。